Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Relmada Therapeutics (RLMD)
NASDAQ:RLMD
RESEARCH TOOLSreports
Holding RLMD?
Track your performance easily
| Sep 24 | Jun 24 | Dec 23 | Sep 23 | Mar 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | $ -83.60K |
| EBIT | $ -21.73M | $ -17.77M | $ -26.83M | $ -22.69M | $ 29.99M |
| EBITDA | $ -21.73M | $ -17.77M | $ -26.83M | $ -22.69M | $ 29.99M |
| Net Income Common Stockholders | $ -21.73M | $ -17.77M | $ -25.17M | $ -22.00M | $ 29.99M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 54.12M | $ 70.44M | $ 96.32M | $ 106.27M | $ 132.44M |
| Total Assets | $ 55.72M | $ 71.03M | $ 97.55M | $ 109.15M | $ 135.57M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -54.12M | $ -70.44M | $ -96.32M | $ -106.27M | $ -132.44M |
| Total Liabilities | $ 8.10M | $ 9.54M | $ 12.19M | $ 8.42M | $ 10.10M |
| Stockholders Equity | $ 47.63M | $ 61.49M | $ 85.36M | $ 100.73M | $ 125.47M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -16.66M | $ -13.26M | $ -10.25M | $ -11.63M | $ -16.51M |
| Operating Cash Flow | $ -16.66M | $ -13.26M | $ -10.25M | $ -11.63M | $ -16.51M |
| Investing Cash Flow | $ 16.14M | $ 14.01M | $ 7.74M | $ 3.86M | $ 40.00M |
| Financing Cash Flow | $ -89.60K | - | $ -98.46K | - | - |